Pyxis Oncology (PYXS): Coastlands Capital LP now owns 5.4% of PYXS as a passive investor 5.4%

5.4%

Stake

6.45M

Shares owned

Stake as of

Oct 1, 2026

Filed

Oct 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 13, 2026Company filing · Form 8-K · ResultsReported its results
2. Sep 3, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 4, 2026, the Board of Directors (the “Board”) of Pyxis Oncology, Inc. (the “Company”) appointed Thomas Civik, the Company’s Interim Chief Executive Officer, to serve as the Company’s permanent Chief Executive Officer, effective immediately (the “Appointment”).”
3. Sep 29, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news

What came next

1. Oct 2, 20265% stakeGordonMD Global Investments LP reported a passive stake (13G) of 17.5%
2. Oct 5, 20265% stakeCoastlands Capital LP reported a passive stake (13G) of 5.4%
3. Oct 9, 20265% stakeGordonMD Global Investments LP reported a passive stake (13G) of 16.4%
4. Nov 3, 20265% stakeLaurion Capital Management LP reported a passive stake (13G) of 5.2%
5. Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
6. Nov 13, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote

How to read SEC Schedule 13G

A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

Full guide: Schedule 13D vs Schedule 13G: what is the difference?

What else is on file for Pyxis Oncology

For Pyxis Oncology, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PYXS page.

How this filing works

• Schedule 13D vs 13G

Other disclosures at Pyxis Oncology

• SEC Form 13F-HRNov 13, 2026
• SEC Form 13F-HRFeb 14, 2025
• SEC Form 4Nov 27, 2024
• SEC Form 4Nov 27, 2024

Everything OQRO holds on this company is on its PYXS page.